why choose us

First received: July 15, 2022

Clinical Trial: Near Patient Molecular Testing in Sepsis

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Sepsis
Systemic Inflammatory Response Syndrome

Study Type: Observational


Official Title: Near Patient Molecular Testing in Sepsis

Brief Summary: The purpose of the study is to evaluate the real-time performance of a new host response test (SeptiCyte RAPID) for differentiating sepsis from non-infection/systemic inflammatory response syndrome among patients suspected of sepsis within the first 24 hours of intensive care unit (ICU) admission.

Read more